NCT05807113View on ClinicalTrials.gov

Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Atopic DiathesisEczema-prone Skin
Interventions
OTHER

Atopi intensive care BNO 3731

Crem twice daily

OTHER

Benchmark product

Crem twice daily

Trial Locations (1)

22869

SGS proderm GmbH, Schenefeld

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY